_id
6919e6053c536f8df2318158
Ticker
CIZ.LSE
Name
Cizzle Biotechnology Holdings PLC
Exchange
LSE
Address
The Shard, London, United Kingdom, SE1 9SG
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.cizzlebiotechnology.com
Description
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Last Close
15500
Volume
58080
Current Price
1.67
Change
0
Last Updated
2025-12-29T15:09:23.346Z
Image
https://logo.clearbit.com/www.cizzlebiotechnology.com
Ipo Date
-
Market Cap
6144072
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
346
Operating Income
-408000
Interest Expense
-
Pretax Income
-381000
Net Income
-368
Eps
-0.0009283739328745282
Dividends Per Share
-
Shares Outstanding
396391773
Income Tax Expense
-13000
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
27000
Cash
182000
Short Term Investments
-
Receivables
72000
Inventories
1000
Total Current Assets
255000
Property Plant Equipment
2000
Total Assets
257000
Payables
383000
Short Term Debt
150000
Long Term Debt
-
Total Liabilities
533000
Equity
-276000
Bs_currency_symbol
GBP
Depreciation
346
Change In Working Capital
7000
Cash From Operations
-331000
Capital Expenditures
2000
Cash From Investing
-2000
Cash From Financing
150000
Net Change In Cash
-183000
Cf_currency_symbol
-
PE
-
PB
-2.39845884057971
ROE
0.13333333333333333
ROA
-0.1431906614785992
FCF
-333000
Fcf Percent
-
Piotroski FScore
0
Health Score
23
Deep Value Investing Score
0.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
4
Net Net Investing Score
0.5
Quality Investing Score
0.5
Value Investing Score
0.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
346
Quarters > 0 > income Statement > operating Income
-408000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-381000
Quarters > 0 > income Statement > net Income
-368
Quarters > 0 > income Statement > eps
-0.0009283739328745282
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
396392
Quarters > 0 > income Statement > income Tax Expense
-13000
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
27000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
182000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
72000
Quarters > 0 > balance Sheet > inventories
1000
Quarters > 0 > balance Sheet > total Current Assets
255000
Quarters > 0 > balance Sheet > property Plant Equipment
2000
Quarters > 0 > balance Sheet > total Assets
257000
Quarters > 0 > balance Sheet > payables
383000
Quarters > 0 > balance Sheet > short Term Debt
150000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
533000
Quarters > 0 > balance Sheet > equity
-276000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-368000
Quarters > 0 > cash Flow > depreciation
346
Quarters > 0 > cash Flow > change In Working Capital
7000
Quarters > 0 > cash Flow > cash From Operations
-331000
Quarters > 0 > cash Flow > capital Expenditures
2000
Quarters > 0 > cash Flow > cash From Investing
-2000
Quarters > 0 > cash Flow > cash From Financing
150000
Quarters > 0 > cash Flow > net Change In Cash
-183000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.0009283739328745282
Quarters > 0 > ratios > PB
-2.39845884057971
Quarters > 0 > ratios > ROE
0.13333333333333333
Quarters > 0 > ratios > ROA
-0.1431906614785992
Quarters > 0 > ratios > FCF
-333000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
23
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
790
Quarters > 1 > income Statement > operating Income
-877701
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-2185579
Quarters > 1 > income Statement > net Income
-755
Quarters > 1 > income Statement > eps
-0.0019035900952803573
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
396619
Quarters > 1 > income Statement > income Tax Expense
-11000
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-1307878
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
365000
Quarters > 1 > balance Sheet > short Term Investments
22000
Quarters > 1 > balance Sheet > receivables
103000
Quarters > 1 > balance Sheet > inventories
2000
Quarters > 1 > balance Sheet > total Current Assets
492000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
492000
Quarters > 1 > balance Sheet > payables
13000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
410000
Quarters > 1 > balance Sheet > equity
82000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-755
Quarters > 1 > cash Flow > depreciation
577
Quarters > 1 > cash Flow > change In Working Capital
15
Quarters > 1 > cash Flow > cash From Operations
-120000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
1000
Quarters > 1 > cash Flow > net Change In Cash
-119000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0019035900952803573
Quarters > 1 > ratios > PB
8.077484512195122
Quarters > 1 > ratios > ROE
-0.9207317073170731
Quarters > 1 > ratios > ROA
-0.15345528455284552
Quarters > 1 > ratios > FCF
-120000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
16
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
299
Quarters > 2 > income Statement > operating Income
-419000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1421000
Quarters > 2 > income Statement > net Income
-1411
Quarters > 2 > income Statement > eps
-0.0000037295679939100464
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
378328000
Quarters > 2 > income Statement > income Tax Expense
-10000
Quarters > 2 > income Statement > EBITDA
-2842000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-1002000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
484000
Quarters > 2 > balance Sheet > short Term Investments
332000
Quarters > 2 > balance Sheet > receivables
107000
Quarters > 2 > balance Sheet > inventories
-107000
Quarters > 2 > balance Sheet > total Current Assets
923000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
923000
Quarters > 2 > balance Sheet > payables
129000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
129000
Quarters > 2 > balance Sheet > equity
794000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-1411
Quarters > 2 > cash Flow > depreciation
299
Quarters > 2 > cash Flow > change In Working Capital
-9
Quarters > 2 > cash Flow > cash From Operations
-238000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
578000
Quarters > 2 > cash Flow > net Change In Cash
340000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0000037295679939100464
Quarters > 2 > ratios > PB
795.7276574307305
Quarters > 2 > ratios > ROE
-0.17770780856423174
Quarters > 2 > ratios > ROA
-0.15287107258938243
Quarters > 2 > ratios > FCF
-238000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
149.5
Quarters > 3 > income Statement > operating Income
-149.5
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-710.5
Quarters > 3 > income Statement > net Income
-705.5
Quarters > 3 > income Statement > eps
-0.0000018647839969550232
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
378328000
Quarters > 3 > income Statement > income Tax Expense
5
Quarters > 3 > income Statement > EBITDA
10
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-710350.5
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
484000
Quarters > 3 > balance Sheet > short Term Investments
332000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
923000
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
923000
Quarters > 3 > balance Sheet > payables
129000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
129000
Quarters > 3 > balance Sheet > equity
794000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-705.5
Quarters > 3 > cash Flow > depreciation
149.5
Quarters > 3 > cash Flow > change In Working Capital
-4.5
Quarters > 3 > cash Flow > cash From Operations
-119
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
289
Quarters > 3 > cash Flow > net Change In Cash
170
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.0000018647839969550232
Quarters > 3 > ratios > PB
795.7276574307305
Quarters > 3 > ratios > ROE
-0.08885390428211587
Quarters > 3 > ratios > ROA
-0.07643553629469121
Quarters > 3 > ratios > FCF
-119
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
1089
Annuals > 0 > income Statement > operating Income
-878000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-2187000
Annuals > 0 > income Statement > net Income
-2166
Annuals > 0 > income Statement > eps
-0.0055900669207919005
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
387473
Annuals > 0 > income Statement > income Tax Expense
-21000
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-1309000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
365000
Annuals > 0 > balance Sheet > short Term Investments
22000
Annuals > 0 > balance Sheet > receivables
103000
Annuals > 0 > balance Sheet > inventories
2000
Annuals > 0 > balance Sheet > total Current Assets
492000
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
492000
Annuals > 0 > balance Sheet > payables
13000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
410000
Annuals > 0 > balance Sheet > equity
82000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-2188000
Annuals > 0 > cash Flow > depreciation
876
Annuals > 0 > cash Flow > change In Working Capital
231000
Annuals > 0 > cash Flow > cash From Operations
-358000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
579000
Annuals > 0 > cash Flow > net Change In Cash
221000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.0055900669207919005
Annuals > 0 > ratios > PB
8.032976829268293
Annuals > 0 > ratios > ROE
-2.6414634146341465
Annuals > 0 > ratios > ROA
-0.44024390243902434
Annuals > 0 > ratios > FCF
-358000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
9
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
1190
Annuals > 1 > income Statement > operating Income
-976000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-1763000
Annuals > 1 > income Statement > net Income
-1717
Annuals > 1 > income Statement > eps
-0.000004824917594229207
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
355861000
Annuals > 1 > income Statement > income Tax Expense
-46000
Annuals > 1 > income Statement > EBITDA
-695
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-787000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
144000
Annuals > 1 > balance Sheet > short Term Investments
1413000
Annuals > 1 > balance Sheet > receivables
136000
Annuals > 1 > balance Sheet > inventories
-1549000
Annuals > 1 > balance Sheet > total Current Assets
1693000
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
1693000
Annuals > 1 > balance Sheet > payables
92000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
186000
Annuals > 1 > balance Sheet > equity
1507000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-1763000
Annuals > 1 > cash Flow > depreciation
976
Annuals > 1 > cash Flow > change In Working Capital
-11000
Annuals > 1 > cash Flow > cash From Operations
-639000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
305000
Annuals > 1 > cash Flow > net Change In Cash
-334000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.000004824917594229207
Annuals > 1 > ratios > PB
401.4357664233577
Annuals > 1 > ratios > ROE
-0.11393497013934971
Annuals > 1 > ratios > ROA
-0.10141760189013585
Annuals > 1 > ratios > FCF
-639000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
0
Annuals > 2 > income Statement > operating Expenses
963000
Annuals > 2 > income Statement > operating Income
-963000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-963000
Annuals > 2 > income Statement > net Income
-912000
Annuals > 2 > income Statement > eps
-0.0031305780584923795
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
291320000
Annuals > 2 > income Statement > income Tax Expense
-51000
Annuals > 2 > income Statement > EBITDA
-963000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
478000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
227000
Annuals > 2 > balance Sheet > inventories
-227
Annuals > 2 > balance Sheet > total Current Assets
705000
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
2785000
Annuals > 2 > balance Sheet > payables
41000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
145000
Annuals > 2 > balance Sheet > equity
2640000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-963000
Annuals > 2 > cash Flow > depreciation
963
Annuals > 2 > cash Flow > change In Working Capital
-57000
Annuals > 2 > cash Flow > cash From Operations
-872000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-120000
Annuals > 2 > cash Flow > cash From Financing
595000
Annuals > 2 > cash Flow > net Change In Cash
-397000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.0031305780584923795
Annuals > 2 > ratios > PB
187.59242424242424
Annuals > 2 > ratios > ROE
-34.54545454545455
Annuals > 2 > ratios > ROA
-32.74685816876122
Annuals > 2 > ratios > FCF
-872000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
0
Annuals > 3 > income Statement > gross Profit
0
Annuals > 3 > income Statement > operating Expenses
851000
Annuals > 3 > income Statement > operating Income
2256000
Annuals > 3 > income Statement > interest Expense
6214000
Annuals > 3 > income Statement > pretax Income
-3958000
Annuals > 3 > income Statement > net Income
-3921000
Annuals > 3 > income Statement > eps
-0.024426862696237228
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
160520000
Annuals > 3 > income Statement > income Tax Expense
-37000
Annuals > 3 > income Statement > EBITDA
-851000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-6214000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
875000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
80000
Annuals > 3 > balance Sheet > inventories
-80
Annuals > 3 > balance Sheet > total Current Assets
955000
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
1155000
Annuals > 3 > balance Sheet > payables
111000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
218000
Annuals > 3 > balance Sheet > equity
937000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-3958000
Annuals > 3 > cash Flow > depreciation
-3107000
Annuals > 3 > cash Flow > change In Working Capital
-197000
Annuals > 3 > cash Flow > cash From Operations
-1009000
Annuals > 3 > cash Flow > capital Expenditures
200000
Annuals > 3 > cash Flow > cash From Investing
-154000
Annuals > 3 > cash Flow > cash From Financing
2031000
Annuals > 3 > cash Flow > net Change In Cash
868000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.024426862696237228
Annuals > 3 > ratios > PB
291.2315901814301
Annuals > 3 > ratios > ROE
-418.4631803628602
Annuals > 3 > ratios > ROA
-339.4805194805195
Annuals > 3 > ratios > FCF
-1209000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.0009283739328745282
Valuation > metrics > PB
-2.39845884057971
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
0.13333333333333333
Profitability > metrics > ROA
-0.14431372549019608
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-15.11111111111111
Risk > final Score
-30
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.47842401500938087
Liquidity > metrics > Quick Ratio
0.47654784240150094
Liquidity > final Score
34
Liquidity > verdict
Weak
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
3
Prev Risks > 1
59
Prev Risks > 2
59
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:00:34.373Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-25
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-04-30
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-09-30
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-03-31
Earnings History > 3 > report Date
2023-04-27
Earnings History > 3 > date
2023-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-09-28
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-03-31
Earnings History > 5 > report Date
2022-05-30
Earnings History > 5 > date
2022-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.01
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.01
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-09-30
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.01
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-03-31
Earnings History > 7 > report Date
2021-05-14
Earnings History > 7 > date
2021-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-09-30
Earnings History > 8 > report Date
2020-10-13
Earnings History > 8 > date
2020-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-06-30
Earnings History > 9 > report Date
2019-09-27
Earnings History > 9 > date
2019-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-03-31
Earnings History > 10 > report Date
2018-06-29
Earnings History > 10 > date
2018-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2017-06-30
Earnings History > 11 > report Date
2017-09-28
Earnings History > 11 > date
2017-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFTSE AIM All-Share Coverage Cizzle Biotechnology (LSE:CIZ) Research and Operations - Kalkine Media
11/18/2025
FTSE AIM All-Share Coverage Cizzle Biotechnology (LSE:CIZ) Research and Operations Kalkine Media
Read more →Cizzle Biotechnology jumps 21% on US commercial progress Proactive financial news
Read more →Showing 2 of 4
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Cizzle Biotechnology Holdings PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.